Dividella - Modular and Flexible Secondary Pharmaceutical Packaging
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here


Modular and Flexible Secondary Packaging

Dividella develops secondary pharmaceutical packaging solutions and systems for vials, ampoules, syringes, pens, combination packs, medical devices, blisters, and many more medical products.

Werdenstrasse 76,
9472 Grabs,

pharmaceutical packaging solutions

Dividella develops secondary pharmaceutical packaging solutions and systems for vials, ampoules, syringes, pens, combination packs, medical devices, blisters, and many more medical products.

Customers in pharmaceutical and biotech companies benefit from extensive engineering support. The company’s specialists find dependable solutions for the safe packaging of sensitive products, optimised pack sizes for the cold chain, and easy-to-use mono material packaging with a low total cost of ownership.

With more than 30 years of experience in packaging and machine development, Dividella’s solutions are sustainable thanks to their unique modularity.

High-quality cartons for the storage and transportation of pharmaceutical products

Dividella’s packaging process begins with toploading box erection. Using the rotor principle, the company’s machines achieve a consistent high-performance and high-quality carton. Once set up from flat carton and partition blanks, the carton is placed on a vacuum conveyor system and is moved through the machine.

Various other proprietary systems such as cameras, inspection, Track &Trace components, and marking systems can be integrated into the machine without any problems.

Fast small-batch pharmaceutical packaging production

Small-quantity packaging production is often needed for applications such as clinical trials, market launches, and market research. It is also often the case that the manufacturer does not have suitable production lines for such a small amount, meaning potential waste and overproduction.

Dividella’s small-batch pharmaceutical packaging production offers a solution, with quick-time-to-market production. All styles of packaging can be produced on Dividella’s flexible and adaptable packaging system NeoTOP, whether for clinical trials or establishing a market presence. For the smallest batch size, the company’s modern facilities can be used for all processes, from plotting, to printing and erecting.

Individually selected product packaging production lines

Dividella implements a customer-orientated service, with a top priority to discover the optimal packaging solution for any client. A suitable machine is chosen from the range, decided by production volume and batch size.

The packaging systems are designed with high attention to detail. Each machine is accurate and optimised for various load sizes. The Neo TOP handles smaller to medium-sized lots, whereas the Neo TOP 804 is designed for medium to large-sized lots.

Dividella’s machines are modular, meaning increased flexibility. An almost unlimited number of packaging can be processed, whether the pharmaceutical product to be packaged is inclusive of a blister, de-nester, thermoformer, or magazine.

Flexible feeding systems for parenterals

Dividella presents a variety of feeding technologies for parenterals. Its wide and flexible range are scalable and customised to assist the packaging of up to 500 objects per feeding unit. Products can be aligned, spread, and individually checked before insertion and linking to upstream machines.

Use of Parenteral Packaging and the latest trends

Users of Dividella’s equipment return time and time again to adapt their existing system or to acquire new lines. The company manufactures quality, easily modifiable, easy-to-use and excellently serviced equipment, which is tailored to the individual needs of the client.

Significant changes have been seen in the packaging of parenterals over the past few years worldwide. However, when speaking of worldwide trends the sustained growth in oncopathology patients and the prevalence of cardiovascular disease and diseases of the respiratory system must be noted.

The parenteral drug segment accounts for 30% of the overall global market of dosage forms. Nearly half of the medicines in this segment are biopharmaceuticals, at 47%. Small molecule inhibitors make up 38%, which in turn consists of 24% preparations for the treatment of oncopathology patients, 20% antibiotics and anti-bacterial agents, and 5% drugs for the treatment of patients with blood disorders. The other 45% consist of medicines for treatment of other illnesses. The vaccine market accounts for 5% of the overall market of parenteral drugs.

NeoTOP 804

When it comes to speed and performance, Dividella's NeoTOP 804 has a three-fold advantage over rival products due to an option that allows the erection, insertion, and sealing of three cartons in a single cycle.

NeoTOP 1604

Increases in market and product segmentation as well as the way modern medicines work means that the already wide variety of secondary packaging is constantly growing.

NeoTOP x

Dividella is accommodating to an increase in market and product segmentation with the NeoTOP x system.

Modular and Digitised Pharma Production

Dividella is working with Medipak Systems sister companies to find new answers to the question of what does modularity offer in the digitisation of industrial production.

Dividella Brochure

In the packaging business, time-to-market is critical. A new product has to be able to be packaged without losing any time and it must be possible to respond within a very short time to marketing or customer requirements.

German Design Award goes to Dividella NeoTRAY cartoner system

Top-loading parenteral and secondary packaging specialist Dividella’s industry NeoTRAY fully automatic cartoner for high-speed parenteral packaging has been honoured for Excellent Product Design in the 2020 German Design Awards.

Dividella’s Approach to Small-Batch Production

Lot Size One is a concept from Pharma 4.0 theory that, in that age of connected data, an individual customer order need no longer be satisfied from stock in the supply chain but might actually trigger a production machine to produce that specific item.

Relieving Pain Points

Striking the right balance on batch size is difficult for any pharmaceutical company. Manufacturing thousands, if not millions, of identical pack iterations allows medicines to be dispatched to customers quickly, albeit without the capacity to cater to individual client needs.

Dividella Launches New NeoTOP Toploading Cartoner

Within the NeoTOP range, the new Toploading cartoner NeoTOP 1604 meets the market's demand for a product-flexible packaging machine, which is able to handle packs with five, ten, or 100 products at a high-level of output.

Factorytalk Transfers MES Business to Werum IT Solutions

International manufacturing execution systems (MES) software supplier Werum IT Solutions has jointly announced the transfer of Southeast Asia-based consultant Factorytalk's manufacturing execution systems (MES) business to Werum's corporate organisation.

Körber Medipak to Attend Pharmaceutical Packaging Technology Conference

Körber Medipak invites its customers from the pharmaceutical industry to MediSeal in Schloß Holte, Stukenbrock. On 18 and 19 May 2010, at the two-day Forum for Pharmaceutical Packaging Technology, the Group's companies will be presenting the latest technological developments in the phar